Summary

The VISION study examined the association of preoperative statin use with 30-day frequency of cardiovascular complications. Data from over 7000 patients who received noncardiac surgery indicate the potential value of preoperative statin use, which was associated with lower 30-day risk of all-cause mortality and myocardial injury at 30 days. VISION was an observational study. Randomized controlled trials are needed.